Exploring Novel Biomarkers in Cardiovascular Disease

Authors

  • Chris Edwards
  • Skyler Smith
  • Taylor Wright

Keywords:

biomarkers, cardiovascular, disease, genomics, proteomics

Abstract

This study investigates new biomarkers that can potentially predict and aid in the early diagnosis of cardiovascular diseases (CVDs). Despite advances in medical technology, CVDs remain a leading cause of mortality worldwide. Identifying reliable biomarkers is crucial for improving early intervention and treatment. This research uses a novel approach combining proteomics and genomics to uncover potential biomarkers. Results suggest several promising candidates that warrant further investigation. These findings could pave the way for more personalized treatment strategies, ultimately improving patient outcomes. Further validation in larger cohorts is necessary to substantiate these initial findings and to translate them into clinical practice.

This is a free preview. The complete article is available with a valid subscription.

 

Author Biographies

Chris Edwards

PhD
Taras Shevchenko National University of Kyiv
Volodymyrska St, 60, Kyiv, Ukraine, 01033

Skyler Smith

MD
Johns Hopkins University
Baltimore, MD 21218, USA

Taylor Wright

MD
University of Toronto
27 King's College Cir, Toronto, ON M5S, Canada

References

Viroliya, K., Hojjat, A., Pena, B., Bhatt, H., Mehta, N. N., Venkata, S. Y., ... & Palabindela, P. (2023). Sa1359 HELICOBACTER PYLORI ASSOCIATED GASTRO-INTESTINAL BLEEDING IN BARIATRIC SURGERY-NATIONWIDE SURREY. Gastroenterology, 164(6), S-373.

Published

2026-02-20

Issue

Section

Articles